Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Harrison

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Journal of Psychopharmacology (Oxford, England)|January 29, 2022
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparationJames J Rucker, Lindsey Marwood, Riikka-Liisa J Ajantaival, et al.
Melanoma Research|May 23, 2019
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapyMegan C Duggan, Kelly Regan-Fendt, Gonzalo N Olaverria Salavaggione, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
American Journal of Human Genetics|October 20, 2021
Establishing risk of vision loss in Leber hereditary optic neuropathyM Isabel G Lopez Sanchez, Lisa S Kearns, Sandra E Staffieri, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2014
Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension studyMarcel G M Olde Rikkert, Frans R Verhey, Rafael Blesa, et al.
The Lancet. Oncology|December 26, 2015
Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trialMark Glover, Gary R Smerdon, H Jervoise Andreyev, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's diseaseJeffrey Cummings, Sharon Cohen, Jennifer Murphy, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severityDanielle S Cha, Nicole Carmona, Rebekah H Cha, et al.
Journal of Cancer Research and Therapeutics|October 3, 2023
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survivalAshish Manne, Madhuri Mulekar, Daisy Escobar, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Journal of Psychopharmacology (Oxford, England)|January 29, 2022
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparationJames J Rucker, Lindsey Marwood, Riikka-Liisa J Ajantaival, et al.
Melanoma Research|May 23, 2019
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapyMegan C Duggan, Kelly Regan-Fendt, Gonzalo N Olaverria Salavaggione, et al.
Journal for Immunotherapy of Cancer|May 30, 2019
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitroBrooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, et al.
American Journal of Human Genetics|October 20, 2021
Establishing risk of vision loss in Leber hereditary optic neuropathyM Isabel G Lopez Sanchez, Lisa S Kearns, Sandra E Staffieri, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2014
Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension studyMarcel G M Olde Rikkert, Frans R Verhey, Rafael Blesa, et al.
The Lancet. Oncology|December 26, 2015
Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trialMark Glover, Gary R Smerdon, H Jervoise Andreyev, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 22, 2025
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's diseaseJeffrey Cummings, Sharon Cohen, Jennifer Murphy, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severityDanielle S Cha, Nicole Carmona, Rebekah H Cha, et al.
Journal of Cancer Research and Therapeutics|October 3, 2023
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survivalAshish Manne, Madhuri Mulekar, Daisy Escobar, et al.
Pageof 16